8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2018 / Randomized controlled trial
An open-label randomized trial assigned 100 participants with coronary artery disease to 8 weeks of a vegan diet or an American Heart Association diet. The vegan diet resulted in a 32% lower high-sensitivity C-reactive protein level compared to the AHA diet (adjusted β, 0.67; 95% CI, 0.47-0.94; P = 0.02). Reductions in body mass index, waist circumference, and glycemic control markers did not differ significantly between groups.
Shah B, Newman JD, Woolf K, et al. J Am Heart Assoc, 2018. PMID 30571591
2018 / Non-randomized controlled trial
In a non-randomized controlled trial, young adults underwent gastrointestinal tolerance tests with stepwise dose escalations of D-allulose. No severe diarrhea or gastrointestinal symptoms appeared up to 0.4 g/kg body weight, but severe diarrhea occurred at 0.5 g/kg body weight. Compared to sugar, D-allulose was linked to higher frequencies of diarrhea (p = 0.004), abdominal distention (p = 0.039), and abdominal pain (p = 0.031), while escalating total daily intake to 1.0 g/kg body weight produced severe nausea, headache, anorexia, and diarrhea.
Han Y, Choi BR, Kim SY, et al. Nutrients, 2018. PMID 30572580
2018 / Randomized controlled trial
Researchers randomized inactive obese patients with type 2 diabetes into three experimental diet groups (low-carbohydrate [LCD], low-fat [LFD], high-fat [HFD]; n=11 each) and a normal diet control group (n=9) over 24 weeks combining diets with 12 weeks of cycle-ergometer HIIT. After 24 weeks, the highest percentage improvements were seen in LCD for glucose (-34.76%), cholesterol (-33.35%), HDL (+41.81%), triglycerides (-40.71%), and weight (-12.49%). The highest percentage reductions in IL-6 (-32.10%), resistin (-28.29%), and leptin (-53.92%) occurred in the LCD group, while LFD showed the largest improvements in TNF-alpha (-48.06%), FGF21 (+55.30%), and adiponectin (+42.32%).
Asle Mohammadi Zadeh M, Kargarfard M, Marandi SM, et al. J Diabetes Metab Disord, 2018. PMID 30918861
2017 / Controlled trial
Forty healthy male volunteers were divided into four groups: head-down-tilt sleeping control, head-down-tilt sleeping hypokinetic, active controls, and hypokinetic subjects. Measurements were taken during a 390-day pre-experimental and a 360-day experimental period. Iliac crest cancellous bone volume, trabecular bone volume, and cortical thickness increased (P<0.05) in the head-down-tilt sleeping hypokinetic group compared to the hypokinetic group, whereas these measures were reduced (P<0.05) in hypokinetic subjects compared to pre-experimental values.
Kakuris KK, Yaroshenko YN, Charapakhin KP, et al. Clin Physiol Funct Imaging, 2017. PMID 26711194
2017 / Randomized, double-blinded crossover trial
In a randomized, double-blinded crossover trial, 21 patients with type 2 diabetes consumed products made from organic ancient khorasan wheat or modern organic control wheat for 8 weeks each, separated by an 8-week washout. The metabolic risk profile improved only after the khorasan intervention, with mean reductions in total cholesterol (-3.7%), LDL cholesterol (-3.4%), insulin (-16.3%), and blood glucose (-9.1%). Khorasan wheat also significantly reduced reactive oxygen species, VEGF, and interleukin-1ra, and increased total antioxidant capacity (+6.3%), whereas modern wheat produced no significant differences from baseline.
Whittaker A, Dinu M, Cesari F, et al. Eur J Nutr, 2017. PMID 26853601
2017 / Randomized controlled trial
A total of 78 newly diagnosed but untreated hypertensive subjects were randomized into three equal groups receiving Hibiscus sabdariffa (HS), lisinopril, or placebo once daily for 4 weeks. HS and lisinopril both significantly increased urine volume compared to placebo (P < 0.001), with HS increasing it significantly more than lisinopril (P < 0.001). Additionally, HS significantly increased creatinine clearance compared to placebo (P < 0.001), whereas lisinopril did not.
Nwachukwu DC, Aneke EI, Nwachukwu NZ, et al. J Physiol Sci, 2017. PMID 27221151
2017 / Randomized controlled trial
Eligible breast cancer patients receiving doxorubicin-based chemotherapy were randomized to an 8-week intervention with high daily onion intake (100 to 160 g/d) or low daily onion intake (30 to 40 g/d). Analyses of 23 participants per group revealed that high onion intake significantly decreased fasting blood glucose and insulin levels relative to low onion intake (P < .001). Post-treatment insulin resistance assessed by HOMA-IR was also significantly lower in the high onion group (P < .05).
Jafarpour-Sadegh F, Montazeri V, Adili A, et al. Integr Cancer Ther, 2017. PMID 27352956
2017 / Repeated-measures crossover trial
Fifteen recreational runners completed a graded exercise protocol followed by four 15-minute treadmill economy trials at 70% of VO2max, conducted 1 hour after consuming one of three energy drinks or a placebo. Fifteen-minute systolic blood pressure was significantly lower in the placebo trials (156.93 ± 15.50) compared to the three energy drink trials (163.87 ± 13.30, 166.47 ± 13.71, and 165.00 ± 15.23). No significant differences were observed for diastolic blood pressure, heart rate, VO2, or rating of perceived exertion.
Peveler WW, Sanders GJ, Marczinski CA, et al. J Strength Cond Res, 2017. PMID 27386963
2017 / Randomized controlled trial
In a preliminary study, 23 women with fibromyalgia were randomized to consume 50 ml of either extra virgin olive oil (EVOO) or refined olive oil (ROO) daily for 3 weeks. Significant differences in pre-post changes were observed between the EVOO and ROO groups for protein carbonyls, lipid peroxidation, FIQ scores, and MCS-12 scores. Differences between groups approached statistical significance for oxidative DNA damage and zinc levels.
NANO counterpoint →
Rus A, Molina F, Ramos MM, et al. Biol Res Nurs, 2017. PMID 27443526
2017 / Randomized double-blind placebo-controlled trial
Seventy patients with non-alcoholic fatty liver disease were randomized to receive 1,200 mg daily of Chlorella vulgaris or placebo for 8 weeks. Weight reduction was significantly greater in the supplemented arm compared to placebo. Between-group differences in mean changes were significant for serum glucose and TNF-α after adjusting for baseline values and insulin (reported adjusted P-values: 0.014, 0.005, 0.014), but not for other measured outcomes.
Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, et al. Clin Nutr, 2017. PMID 27475283
2017 / Multicenter, randomized, double-blind, placebo-controlled trial
A 6-month trial evaluated oral chondroitin sulfate (1,200 mg) plus glucosamine sulfate (1,500 mg) daily versus placebo in 164 patients with symptomatic knee osteoarthritis. In the modified intent-to-treat population, combination therapy was inferior to placebo for joint pain reduction (mean ± SEM change in VAS pain -11.8 ± 2.4 mm [19%] vs. -20.5 ± 2.4 mm [33%], between-group difference 8.7 mm, P < 0.03), though no difference was seen in per-protocol completers. Total WOMAC scores, WOMAC pain and function subscales, OMERACT-OARSI response rates, and rescue medication use did not differ between groups. Severe adverse events were uncommon and distributed equally.
Roman-Blas JA, Castañeda S, Sánchez-Pernaute O, et al. Arthritis Rheumatol, 2017. PMID 27477804
2017 / Randomized controlled trial
Adults from seven European countries were randomized to conventional dietary advice or personalized nutrition advice based on diet, phenotype, or genotype. Among 1,269 participants completing the 6-month trial, personalized nutrition reduced intake of red meat (-5.48 g, 95% CI: -10.8 to -0.09, P = 0.046), salt (-0.65 g, 95% CI: -1.1 to -0.25, P = 0.002), and saturated fat (-1.14% of energy, P < 0.0001), while raising Healthy Eating Index scores (1.27, P = 0.010). Adding phenotypic or genotypic data did not enhance effectiveness.
Celis-Morales C, Livingstone KM, Marsaux CF, et al. Int J Epidemiol, 2017. PMID 27524815
2017 / Double-blind, placebo-controlled trial
A double-blind, placebo-controlled trial examined the effects of 12 weeks of daily supplementation with 50 mg or 150 mg of a water-soluble CoQ10 (Q10Vital®) in 33 healthy subjects. Intake of CoQ10 limited seasonal deterioration of viscoelasticity, significantly reduced wrinkles and microrelief lines, and improved skin smoothness. No significant changes were observed in minimal erythema dose, skin hydration, or dermis thickness.
Žmitek K, Pogačnik T, Mervic L, et al. Biofactors, 2017. PMID 27548886
2017 / Monocentric, randomized, parallel-group, placebo-controlled trial
A 4-month randomized, parallel-group, placebo-controlled trial evaluated daily apple consumption in 250 mildly hypercholesterolaemic healthy subjects divided into five groups of 50 (28 men and 22 women per group). Four groups received one apple per day (Red Delicious, Granny Smith, Fuji, or Golden Delicious), while the fifth group consumed two Annurca apples per day. Annurca apple consumption reduced total cholesterol by 8.3% and LDL cholesterol by 14.5%, and increased HDL cholesterol by 15.2% (all P < 0.001), achieving the most significant outcome among the tested cultivars.
Tenore GC, Caruso D, Buonomo G, et al. J Sci Food Agric, 2017. PMID 27571713
2017 / Randomized controlled trial
In this randomized trial of 55 patients with rheumatoid arthritis, daily intake of 500 mg pomegranate extract for 8 weeks significantly lowered Disease Activity Score 28 (P<0.001), tender and swollen joints, pain intensity, and erythrocyte sedimentation rate compared to placebo. Supplementation also decreased Health Assessment Questionnaire scores (P=0.007) and raised glutathione peroxidase concentrations (P<0.001). However, changes in matrix metalloproteinases 3, C-reactive protein, and malondialdehyde did not differ between groups.
Ghavipour M, Sotoudeh G, Tavakoli E, et al. Eur J Clin Nutr, 2017. PMID 27577177
2017 / Comparative crossover trial
Researchers evaluated the effect of no mouthwash, a water mouthwash, and a menthol mouthwash on crisp aftertaste perception and appetite. In the appetite study with 36 subjects, the water mouthwash did not alter desire, liking, hunger, thirst, or ad libitum intake. In contrast, the menthol mouthwash significantly reduced crisp desire, liking, hunger, and thirst, and lowered ad libitum crisp intake by 29% over a 12-minute period.
Hutchings SC, Horner KM, Dible VA, et al. Appetite, 2017. PMID 27663531
2017 / Crossover trial
Nine active men completed unilateral lower-body resistance exercise followed by either 10 minutes of cold water immersion (10°C) or 10 minutes of low-intensity cycling on separate days at least 1 week apart. Exercise significantly increased intramuscular neutrophil and macrophage counts, MAC1 and CD163 mRNA expression, pro-inflammatory cytokines, neurotrophins, and altered heat shock protein levels (P < 0.05). However, changes in inflammatory cells, cytokines, neurotrophins, and heat shock proteins did not differ significantly between the recovery treatments.
Peake JM, Roberts LA, Figueiredo VC, et al. J Physiol, 2017. PMID 27704555
2017 / Randomized controlled trial
A randomized, double-blind trial gave 44 overweight or obese adults either yeast beta-glucan (up to 954 mg daily) or placebo for six weeks. Compared to placebo, beta-glucan significantly reduced waist circumference (p = 0.037), blood pressure (p = 0.006), and IL-6 at week six (p = 0.005), while increasing IL-10 (p < 0.001). No significant differences appeared in lipid profiles, liver and kidney markers, or nutrient intake.
Mosikanon K, Arthan D, Kettawan A, et al. J Diet Suppl, 2017. PMID 27715351
2017 / Randomized controlled trial
In an 81-patient randomized trial of overweight and obese women with type 2 diabetes on a weight loss program, replacing diet beverages with water after lunch 5 times per week resulted in greater decreases in weight (-6.40 ± 2.42 kg vs -5.25 ± 1.60 kg; P = .006) and BMI (-2.49 ± 0.92 kg/m2 vs -2.06 ± 0.62 kg/m2; P = .006) over 24 weeks compared to continuing diet beverages. The water group also achieved significantly greater reductions in fasting plasma glucose, fasting insulin, HOMA-IR, and 2-hour postprandial glucose. However, no significant time × group interaction was found for waist circumference, lipid profiles, or HbA1c.
Madjd A, Taylor MA, Delavari A, et al. Diabetes Obes Metab, 2017. PMID 27748014
2017 / Randomized crossover trial
In a randomized crossover trial, 10 males completed 60 minutes of submaximal cycling followed by a 10-km time trial while consuming plain water or coconut water. Time trial performance did not significantly differ between coconut water and plain water (971.4 ± 50.5 versus 966.6 ± 44.8 seconds, p = .698). Voluntary intake was lower with coconut water (115 ± 95.41 ml versus 208.7 ± 86.22 ml, p < .001).
Peart DJ, Hensby A, Shaw MP Int J Sport Nutr Exerc Metab, 2017. PMID 27768399
2017 / Randomized controlled trial
In a double-blind pilot study, 10 older adults with mild cognitive decline received an active grape formulation or placebo for six months. Participants taking the grape formulation maintained cerebral metabolism on FDG-PET scans, whereas the placebo group experienced significant metabolic declines in posterior cingulate and temporal regions (p < 0.05). Neuropsychological test scores did not differ significantly between groups.
Lee J, Torosyan N, Silverman DH Exp Gerontol, 2017. PMID 27856335
2017 / Crossover trial
Ten normal fasting subjects consumed a high-fat, high-calorie (HFHC) meal with or without 30 g of insoluble dietary fiber across two visits, with blood sampled over 5 hours. Adding fiber significantly lowered glucose excursion in the first 90 minutes and increased insulin and C-peptide secretion over the 5-hour period compared with the meal alone. The fiber addition prevented increases in lipopolysaccharide (LPS) and significantly reduced meal-induced increases in reactive oxygen species generation, as well as the expression of IL-1β, TNF-α, TLR-4, CD14, SOCS-3, and PTP-1B.
Ghanim H, Batra M, Abuaysheh S, et al. J Clin Endocrinol Metab, 2017. PMID 27906549
2017 / Randomized crossover trial
A randomized crossover trial in 30 healthy men compared mid-morning preloads sweetened with aspartame, monk fruit, stevia, or sucrose (65 g). Ad libitum lunch intake was higher after non-nutritive sweetener drinks than sucrose (P = 0.010), leading to full compensation and no difference in total daily energy intake (P = 0.831). Three-hour total area under the curve for glucose (P = 0.960) and insulin (P = 0.216) did not differ among the four beverages.
Tey SL, Salleh NB, Henry J, et al. Int J Obes (Lond), 2017. PMID 27956737
2017 / Randomized controlled crossover trial
Fifteen healthy participants received a 50 g glucose challenge alone or supplemented with either 25 g ground Salba-chia or 31.5 g flax on three separate occasions. Both Salba-chia and flax reduced the 120-min blood glucose area under the curve by 82.5±19.7 mmol/l (P<0.001) and 60.0±19.7 mmol/l (P=0.014), respectively, relative to control. Compared with flax, Salba-chia reduced peak glucose by -0.64±0.24 mmol/l (P=0.030), increased time to peak by 11.3±3.8 min (P=0.015), and significantly reduced overall appetite score (-6±2 mm; P=0.012). Viscosity was 49.9 Pa·s for Salba-chia, 2.5 Pa·s for flax, and 0.002 Pa·s for control.
Vuksan V, Choleva L, Jovanovski E, et al. Eur J Clin Nutr, 2017. PMID 28000689